IU Health Cancer Center – Lafayette earns three-year radiation oncology accreditation

The Indiana University Health Cancer Center – Lafayette has been awarded a three-year term of gold seal accreditation in radiation oncology as the result of a recent review by the American College of Radiology® (ACR).

Radiation oncology (radiation therapy) is a cancer treatment option that delivers high-dose radiation directly to the tumor while sparing surrounding healthy tissues. Radiation may be used alone or in combination with chemotherapy and surgery to treat cancer.

“This reaccreditation matters, because it’s an external confirmation that our technology, our processes and our clinical judgment meet the highest national standards, when it matters most,” says IU Health Arnett radiation oncologist Matthew Orton, MD. “For patients, it means this lifesaving care is being delivered with rigor, consistency and an unwavering focus on safety.”

The ACR is the nation’s oldest and most widely accepted radiation oncology accrediting body. The ACR gold seal of accreditation represents the highest level of quality and patient safety. It is awarded only to facilities meeting specific requirements-based practice guidelines and technical standards developed by ACR after a peer-review evaluation by board-certified radiation oncologists and medical physicists who are experts in the field.

Patient care and treatment, patient safety, personnel qualifications, adequacy of facility equipment, quality control procedures and quality assurance programs are assessed.

The future of cancer care in Greater Lafayette

This reaccreditation comes as Indiana University Health prepares to begin construction this summer on the new IU Health Cancer Center – Lafayette on the Arnett Hospital campus as part of the Greater Lafayette Community Growth Project, a $214 million investment by IU Health in a three-part project that will also include the construction of the first hospital in West Lafayette.

The new state-of-the-art cancer center, expected to open in 2028, will create a more integrated patient care experience across the healthcare continuum. The 55,000-square foot facility will have room to provide essential infusion therapies to 31 patients simultaneously—a 19% increase over the current facility—in an environment that is intentionally designed to support whole-person care for patients’ bodies, minds and spirits through integrative services such as art therapy, massage therapy, music therapy, support groups, yoga for relaxation and spiritual care.

Additionally, the new Cancer Center will include an oncology rapid access clinic and will house two linear accelerators, advanced radiation therapy technologies and precision genomics services—delivered through a multidisciplinary care approach and the clinical expertise of a team of board-certified physicians.